EXPRESSION OF SURVIVIN IN ORAL MALIGNANCY AND PREMALIGNANCY
Main Article Content
Abstract
ABSTRACT: Oral potentially malignant disorders (OPMDs) have the risk of transformation into Oral squamous cell carcinoma (OSCC) therefore some new biomarkers are required to identify OPMDs at high risk of invasive transformation and to assess the aggressiveness of the tumor and disease progression to OSCC. Survivin inhibits apoptosis of protein (IAP). Survivin has a dual function both in cell cycle promotion and apoptosis inhibition.
Objectives: To assess the immunohistochemical expression of survivin in OSCC, OPMDs, and normal oral mucosa.
Materials and methods: This study comprised of 25 already diagnosed cases of OPMDs, 25 cases of OSCC and 25 normal oral mucosa as a control. Immunohistochemical expression of survivin was analyzed.
Results: Immunoreactivity for survivin was found positive in 60% cases of OPMDs and 100% in OSCC but was absent in normal oral mucosa only one case showed mild staining intensity.
Conclusion: A statistically significant expression of survivin was observed in OPMDs which may indicate the probability of their transformation to OSCC.
Keywords: Oral Potentially Malignant Disorders, Oral Squamous Cell Carcinoma, Survivin, Immunohistochemisrty.
Article Details

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
All articles published in the Journal of Medical Sciences (JMS) are licensed under the Creative Commons Attribution 4.0 International License (CC-BY 4.0). Under the CC BY 4.0 license, author(s) retain the ownership of the copyright publishing rights without restrictions for their content, and allow others to copy, use, print, share, modify, and distribute the content of the article even for commercial purposes as long as the original authors and the journal are properly cited. No permission is required from the author/s or the publishers for this purpose. Appropriate attribution can be provided by simply citing the original article. The corresponding author has the right to grant on behalf of all authors, a worldwide license to JMS and its licensees in all forms, formats, and media (whether known now or created in the future), The corresponding author must certify and warrant the authorship and proprietorship and should declare that he/she has not granted or assigned any of the article’s rights to any other person or body.
The corresponding author must compensate the journal for any costs, expenses, or damages that the JMS may incur as a result of any breach of these warranties including any intentional or unintentional errors, omissions, copyright issues, or plagiarism. The editorial office must be notified upon submission if an article contains materials like text, pictures, tables, or graphs from other copyrighted sources. The JMS reserves the right to remove any images, figures, tables, or other content, from any article, whether before or after publication, if concerns are raised about copyright, license, or permissions and the authors are unable to provide documentation confirming that appropriate permissions were obtained for publication of the content in question.